0001415889-24-020004.txt : 20240723 0001415889-24-020004.hdr.sgml : 20240723 20240723204245 ACCESSION NUMBER: 0001415889-24-020004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240719 FILED AS OF DATE: 20240723 DATE AS OF CHANGE: 20240723 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tahir Misbah CENTRAL INDEX KEY: 0001787359 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39045 FILM NUMBER: 241135911 MAIL ADDRESS: STREET 1: 325 E. MIDDLEFIELD ROAD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IGM Biosciences, Inc. CENTRAL INDEX KEY: 0001496323 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 770349194 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 325 E MIDDLEFIELD ROAD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650-965-7873 MAIL ADDRESS: STREET 1: 325 E MIDDLEFIELD ROAD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 FORMER COMPANY: FORMER CONFORMED NAME: Palingen, Inc. DATE OF NAME CHANGE: 20100712 4 1 form4-07242024_120741.xml X0508 4 2024-07-19 0001496323 IGM Biosciences, Inc. IGMS 0001787359 Tahir Misbah C/O IGM BIOSCIENCES, INC. 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 false true false false CHIEF FINANCIAL OFFICER 0 Common Stock 2024-07-19 4 A 0 33111 A 121959 D Common Stock 2024-07-19 4 A 0 2222 A 124181 D Stock Option (right to buy) 40.27 2024-07-19 4 D 0 55000 D 2030-02-05 Common Stock 55000 0 D Stock Option (right to buy) 91.50 2024-07-19 4 D 0 40000 D 2031-02-19 Common Stock 40000 0 D These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-half of the RSUs shall vest on July 19, 2025 and one-eighth of the RSUs shall vest each three-month anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date. Pursuant to the Issuer's previously disclosed option exchange program, on July 19, 2024 the Issuer cancelled the Reporting Person's options to purchase 55,000 shares and 40,000 shares of the Issuer's Common Stock and in exchange issued aggregate RSU grants of 33,111 shares and 2,222 shares. These securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-half of the RSUs shall vest on January 19, 2026 and one-twelfth of the RSUs shall vest each three-month anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date. /s/ Misbah Tahir 2024-07-23